To describe a case of malignancy-associated hypercoagulability leading to multiple cerebral infarcts in a patient with advanced gastric signet-ring cell carcinoma.
Approach:
Method: A
Method: 7
Method: 6
Method: y
Method: e
Method: r
Method: o
Method: l
Method: d
Method: m
Method: n
Method: w
Method: i
Method: t
Method: h
Method: v
Method: c
Method: g
Method: s
Method: p
Method: u
Method: f
Method: b
Method: ,
Method: x
Key Findings:
The patient exhibited markedly elevated D-dimer levels, indicative of sustained coagulation activation.
Despite anticoagulation, D-dimer levels remained high, suggesting persistent hypercoagulability.
Initiation of systemic chemotherapy correlated with a decline in D-dimer levels and improvement in neurological deficits.
Interpretation:
The case highlights the relationship between tumor burden and systemic hypercoagulability.
Limitations:
The case study is based on a single patient, limiting generalizability.
The exact mechanisms linking tumor burden to hypercoagulability remain incompletely understood.
Conclusion:
Effective tumor-directed therapy may be necessary to mitigate cancer-related thrombotic complications.
In the first installment of a new series on the investment environment in cell and gene therapy, Circio CEO Erik Wiklund explains how he had to get creative to raise funds in a difficult biotech market
